- Home
- SWKH vs NVCT Comparison
SWKH vs NVCT Comparison
Compare SWKH & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWKH
- NVCT
- Stock Information
- Founded
- SWKH 1996
- NVCT 2020
- Country
- SWKH United States
- NVCT United States
- Employees
- SWKH N/A
- NVCT N/A
- Industry
- SWKH Diversified Financial Services
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- SWKH Finance
- NVCT Health Care
- Exchange
- SWKH Nasdaq
- NVCT Nasdaq
- Market Cap
- SWKH N/A
- NVCT 170.3M
- IPO Year
- SWKH 1999
- NVCT 2022
- Fundamental
- Price
- SWKH $17.42
- NVCT $9.35
- Analyst Decision
- SWKH
- NVCT Strong Buy
- Analyst Count
- SWKH 0
- NVCT 2
- Target Price
- SWKH N/A
- NVCT $15.00
- AVG Volume (30 Days)
- SWKH 8.5K
- NVCT 127.6K
- Earning Date
- SWKH 03-19-2025
- NVCT 05-06-2025
- Dividend Yield
- SWKH N/A
- NVCT N/A
- EPS Growth
- SWKH N/A
- NVCT N/A
- EPS
- SWKH 1.08
- NVCT N/A
- Revenue
- SWKH $27,546,000.00
- NVCT N/A
- Revenue This Year
- SWKH $52.93
- NVCT N/A
- Revenue Next Year
- SWKH N/A
- NVCT N/A
- P/E Ratio
- SWKH $16.10
- NVCT N/A
- Revenue Growth
- SWKH N/A
- NVCT N/A
- 52 Week Low
- SWKH $15.14
- NVCT $4.44
- 52 Week High
- SWKH $18.09
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- SWKH 60.86
- NVCT 56.56
- Support Level
- SWKH $16.85
- NVCT $8.45
- Resistance Level
- SWKH $17.98
- NVCT $10.71
- Average True Range (ATR)
- SWKH 0.41
- NVCT 1.01
- MACD
- SWKH 0.10
- NVCT 0.03
- Stochastic Oscillator
- SWKH 78.38
- NVCT 57.01
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.